| Symbol |
Name |
Standardized Value |
|
CRP
|
C-reactive protein, pentraxin-related
|
3.22
|
|
NPPB
|
natriuretic peptide B
|
3.013
|
|
TNNI3
|
troponin I type 3 (cardiac)
|
2.75
|
|
IL1B
|
interleukin 1, beta
|
2.72
|
|
IL6
|
interleukin 6
|
2.684
|
|
ACE2
|
angiotensin I converting enzyme 2
|
2.681
|
|
ACE
|
angiotensin I converting enzyme
|
2.675
|
|
CKB
|
creatine kinase, brain
|
2.596
|
|
CKMT2
|
creatine kinase, mitochondrial 2 (sarcomeric)
|
2.594
|
|
CKM
|
creatine kinase, muscle
|
2.594
|
|
CKMT1B
|
creatine kinase, mitochondrial 1B
|
2.593
|
|
IL1A
|
interleukin 1, alpha
|
2.593
|
|
TNF
|
tumor necrosis factor
|
2.558
|
|
PRG4
|
proteoglycan 4
|
2.521
|
|
MEFV
|
Mediterranean fever
|
2.474
|
|
ALB
|
albumin
|
2.471
|
|
CD4
|
CD4 molecule
|
2.421
|
|
IFNG
|
interferon, gamma
|
2.401
|
|
TNNT2
|
troponin T type 2 (cardiac)
|
2.395
|
|
NLRP3
|
NLR family, pyrin domain containing 3
|
2.389
|
|
GPT
|
glutamic-pyruvate transaminase (alanine aminotransferase)
|
2.384
|
|
IL18
|
interleukin 18
|
2.383
|
|
REN
|
renin
|
2.337
|
|
PRTN3
|
proteinase 3
|
2.328
|
|
ADA
|
adenosine deaminase
|
2.323
|
|
CD8A
|
CD8a molecule
|
2.312
|
|
PIK3C2A
|
phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 alpha
|
2.274
|
|
F3
|
coagulation factor III (thromboplastin, tissue factor)
|
2.217
|
|
MPO
|
myeloperoxidase
|
2.198
|
|
IL10
|
interleukin 10
|
2.173
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
2.171
|
|
F2
|
coagulation factor II (thrombin)
|
2.153
|
|
AGT
|
angiotensinogen (serpin peptidase inhibitor, clade A, member 8)
|
2.146
|
|
IL2
|
interleukin 2
|
2.128
|
|
MYH14
|
myosin, heavy chain 14, non-muscle
|
2.127
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
2.125
|
|
CD68
|
CD68 molecule
|
2.114
|
|
CD274
|
CD274 molecule
|
2.1
|
|
IFNA1
|
interferon, alpha 1
|
2.094
|
|
IL1RN
|
interleukin 1 receptor antagonist
|
2.085
|
|
SNRNP70
|
small nuclear ribonucleoprotein 70kDa (U1)
|
2.065
|
|
TRIM21
|
tripartite motif containing 21
|
2.055
|
|
IL17A
|
interleukin 17A
|
2.05
|
|
CASP1
|
caspase 1, apoptosis-related cysteine peptidase
|
2.046
|
|
MB
|
myoglobin
|
2.028
|
|
TGFB1
|
transforming growth factor, beta 1
|
1.97
|
|
PDCD1
|
programmed cell death 1
|
1.967
|
|
IL1R1
|
interleukin 1 receptor, type I
|
1.952
|
|
TNFRSF1A
|
tumor necrosis factor receptor superfamily, member 1A
|
1.942
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
1.934
|
|
NPPA
|
natriuretic peptide A
|
1.922
|
|
VWF
|
von Willebrand factor
|
1.921
|
|
TMPRSS2
|
transmembrane protease, serine 2
|
1.92
|
|
PF4
|
platelet factor 4
|
1.918
|
|
IL4
|
interleukin 4
|
1.898
|
|
GPT2
|
glutamic pyruvate transaminase (alanine aminotransferase) 2
|
1.853
|
|
CXCL10
|
chemokine (C-X-C motif) ligand 10
|
1.85
|
|
TRIM37
|
tripartite motif containing 37
|
1.845
|
|
CSF2
|
colony stimulating factor 2 (granulocyte-macrophage)
|
1.845
|
|
CSF3
|
colony stimulating factor 3 (granulocyte)
|
1.843
|
|
GJA5
|
gap junction protein, alpha 5, 40kDa
|
1.838
|
|
TLR4
|
toll-like receptor 4
|
1.836
|
|
INS
|
insulin
|
1.83
|
|
IFNA2
|
interferon, alpha 2
|
1.825
|
|
SSB
|
Sjogren syndrome antigen B (autoantigen La)
|
1.823
|
|
CYP3A4
|
cytochrome P450, family 3, subfamily A, polypeptide 4
|
1.813
|
|
C3
|
complement component 3
|
1.796
|
|
SCN5A
|
sodium channel, voltage gated, type V alpha subunit
|
1.787
|
|
IL5
|
interleukin 5
|
1.785
|
|
IFNA17
|
interferon, alpha 17
|
1.776
|
|
ATP4A
|
ATPase, H+/K+ exchanging, alpha polypeptide
|
1.767
|
|
NR3C2
|
nuclear receptor subfamily 3, group C, member 2
|
1.767
|
|
ATP12A
|
ATPase, H+/K+ transporting, nongastric, alpha polypeptide
|
1.763
|
|
IFNA10
|
interferon, alpha 10
|
1.75
|
|
IFNA6
|
interferon, alpha 6
|
1.749
|
|
IFNA16
|
interferon, alpha 16
|
1.748
|
|
IFNA13
|
interferon, alpha 13
|
1.747
|
|
IFNA14
|
interferon, alpha 14
|
1.747
|
|
IFNA21
|
interferon, alpha 21
|
1.747
|
|
IFNA7
|
interferon, alpha 7
|
1.747
|
|
IFNA8
|
interferon, alpha 8
|
1.746
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
1.746
|
|
IFIH1
|
interferon induced with helicase C domain 1
|
1.746
|
|
IFNA5
|
interferon, alpha 5
|
1.745
|
|
IFNA4
|
interferon, alpha 4
|
1.741
|
|
PLAT
|
plasminogen activator, tissue
|
1.737
|
|
MVK
|
mevalonate kinase
|
1.734
|
|
IFNB1
|
interferon, beta 1, fibroblast
|
1.722
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
1.72
|
|
NOD2
|
nucleotide-binding oligomerization domain containing 2
|
1.717
|
|
APOH
|
apolipoprotein H (beta-2-glycoprotein I)
|
1.715
|
|
VCAM1
|
vascular cell adhesion molecule 1
|
1.707
|
|
TTN
|
titin
|
1.701
|
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1
|
1.699
|
|
ICAM1
|
intercellular adhesion molecule 1
|
1.694
|
|
TLR2
|
toll-like receptor 2
|
1.684
|
|
CD19
|
CD19 molecule
|
1.684
|
|
EDN1
|
endothelin 1
|
1.681
|
|
IL33
|
interleukin 33
|
1.678
|
|
PTPRC
|
protein tyrosine phosphatase, receptor type, C
|
1.665
|
|
IL1RAP
|
interleukin 1 receptor accessory protein
|
1.663
|
|
TLR7
|
toll-like receptor 7
|
1.662
|
|
IL13
|
interleukin 13
|
1.662
|
|
GJA1
|
gap junction protein, alpha 1, 43kDa
|
1.66
|
|
MMEL1
|
membrane metallo-endopeptidase-like 1
|
1.655
|
|
SELE
|
selectin E
|
1.653
|
|
CD28
|
CD28 molecule
|
1.636
|
|
TNFSF13B
|
tumor necrosis factor (ligand) superfamily, member 13b
|
1.629
|
|
RYR2
|
ryanodine receptor 2 (cardiac)
|
1.625
|
|
MME
|
membrane metallo-endopeptidase
|
1.615
|
|
HP
|
haptoglobin
|
1.613
|
|
FURIN
|
furin (paired basic amino acid cleaving enzyme)
|
1.61
|
|
PF4V1
|
platelet factor 4 variant 1
|
1.603
|
|
LGALS3
|
lectin, galactoside-binding, soluble, 3
|
1.596
|
|
KCNH2
|
potassium channel, voltage gated eag related subfamily H, member 2
|
1.585
|
|
PLG
|
plasminogen
|
1.583
|
|
CD80
|
CD80 molecule
|
1.581
|
|
CCL3
|
chemokine (C-C motif) ligand 3
|
1.579
|
|
GLS2
|
glutaminase 2 (liver, mitochondrial)
|
1.579
|
|
IL7
|
interleukin 7
|
1.571
|
|
SELP
|
selectin P (granule membrane protein 140kDa, antigen CD62)
|
1.571
|
|
GLS
|
glutaminase
|
1.57
|
|
EPO
|
erythropoietin
|
1.568
|
|
SLC5A2
|
solute carrier family 5 (sodium/glucose cotransporter), member 2
|
1.566
|
|
CD86
|
CD86 molecule
|
1.56
|
|
MYD88
|
myeloid differentiation primary response 88
|
1.559
|
|
THBD
|
thrombomodulin
|
1.556
|
|
TTR
|
transthyretin
|
1.553
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
1.551
|
|
CALB2
|
calbindin 2
|
1.546
|
|
TOP2B
|
topoisomerase (DNA) II beta 180kDa
|
1.539
|
|
SERPINC1
|
serpin peptidase inhibitor, clade C (antithrombin), member 1
|
1.536
|
|
MMP9
|
matrix metallopeptidase 9
|
1.525
|
|
GSDMD
|
gasdermin D
|
1.523
|
|
EXOSC10
|
exosome component 10
|
1.519
|
|
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1
|
1.518
|
|
FCGR3B
|
Fc fragment of IgG, low affinity IIIb, receptor (CD16b)
|
1.518
|
|
EGFR
|
epidermal growth factor receptor
|
1.512
|
|
FCGR3A
|
Fc fragment of IgG, low affinity IIIa, receptor (CD16a)
|
1.509
|
|
AVP
|
arginine vasopressin
|
1.508
|
|
ERVW-1
|
endogenous retrovirus group W, member 1
|
1.507
|
|
JAK2
|
Janus kinase 2
|
1.504
|
|
CD34
|
CD34 molecule
|
1.501
|
|
FN1
|
fibronectin 1
|
1.499
|
|
PRF1
|
perforin 1 (pore forming protein)
|
1.489
|
|
TLR9
|
toll-like receptor 9
|
1.487
|
|
TLR3
|
toll-like receptor 3
|
1.475
|
|
CEACAM5
|
carcinoembryonic antigen-related cell adhesion molecule 5
|
1.468
|
|
CD40LG
|
CD40 ligand
|
1.467
|
|
MSLN
|
mesothelin
|
1.466
|
|
CD1E
|
CD1e molecule
|
1.461
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
1.46
|
|
MYH7
|
myosin, heavy chain 7, cardiac muscle, beta
|
1.459
|
|
CD1A
|
CD1a molecule
|
1.459
|
|
CD1B
|
CD1b molecule
|
1.459
|
|
GDF15
|
growth differentiation factor 15
|
1.458
|
|
ERV3-1
|
endogenous retrovirus group 3, member 1
|
1.451
|
|
ERVFRD-1
|
endogenous retrovirus group FRD, member 1
|
1.45
|
|
MYOM2
|
myomesin 2
|
1.448
|
|
CCL5
|
chemokine (C-C motif) ligand 5
|
1.448
|
|
FABP3
|
fatty acid binding protein 3, muscle and heart
|
1.444
|
|
AGTR1
|
angiotensin II receptor, type 1
|
1.443
|
|
JAK1
|
Janus kinase 1
|
1.443
|
|
POMC
|
proopiomelanocortin
|
1.438
|
|
ADAMTS13
|
ADAM metallopeptidase with thrombospondin type 1 motif, 13
|
1.435
|
|
CXCL9
|
chemokine (C-X-C motif) ligand 9
|
1.433
|
|
C4A
|
complement component 4A (Rodgers blood group)
|
1.432
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
1.43
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
1.427
|
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
1.424
|
|
IL18BP
|
interleukin 18 binding protein
|
1.422
|
|
HMGCR
|
3-hydroxy-3-methylglutaryl-CoA reductase
|
1.422
|
|
RO60
|
Ro60, Y RNA binding protein
|
1.419
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
1.417
|
|
HSPD1
|
heat shock 60kDa protein 1 (chaperonin)
|
1.417
|
|
FOXP3
|
forkhead box P3
|
1.415
|
|
CD1D
|
CD1d molecule
|
1.413
|
|
CD163
|
CD163 molecule
|
1.411
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
1.408
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
1.407
|
|
NLRC4
|
NLR family, CARD domain containing 4
|
1.406
|
|
DPP4
|
dipeptidyl-peptidase 4
|
1.404
|
|
MYBPC3
|
myosin binding protein C, cardiac
|
1.402
|
|
CD1C
|
CD1c molecule
|
1.402
|
|
GZMB
|
granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1)
|
1.399
|
|
ALK
|
anaplastic lymphoma receptor tyrosine kinase
|
1.397
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
1.397
|
|
SELL
|
selectin L
|
1.393
|
|
CYBB
|
cytochrome b-245, beta polypeptide
|
1.392
|
|
NLRP12
|
NLR family, pyrin domain containing 12
|
1.385
|
|
KCNJ2
|
potassium channel, inwardly rectifying subfamily J, member 2
|
1.385
|
|
SAA1
|
serum amyloid A1
|
1.384
|
|
CD40
|
CD40 molecule, TNF receptor superfamily member 5
|
1.384
|
|
ITPKC
|
inositol-trisphosphate 3-kinase C
|
1.383
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
1.382
|
|
CCL4
|
chemokine (C-C motif) ligand 4
|
1.38
|
|
FCGR2A
|
Fc fragment of IgG, low affinity IIa, receptor (CD32)
|
1.38
|
|
IL22
|
interleukin 22
|
1.376
|
|
PTH
|
parathyroid hormone
|
1.376
|
|
KNG1
|
kininogen 1
|
1.374
|
|
CCN2
|
cellular communication network factor 2
|
1.371
|
|
P2RY12
|
purinergic receptor P2Y, G-protein coupled, 12
|
1.37
|
|
NCAM1
|
neural cell adhesion molecule 1
|
1.367
|
|
FBL
|
fibrillarin
|
1.363
|
|
ITGAM
|
integrin, alpha M (complement component 3 receptor 3 subunit)
|
1.36
|
|
PDCD1LG2
|
programmed cell death 1 ligand 2
|
1.355
|
|
DNAH8
|
dynein, axonemal, heavy chain 8
|
1.353
|
|
S100A12
|
S100 calcium binding protein A12
|
1.351
|
|
TP53
|
tumor protein p53
|
1.349
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
1.349
|
|
TPO
|
thyroid peroxidase
|
1.347
|
|
PECAM1
|
platelet/endothelial cell adhesion molecule 1
|
1.346
|
|
FIP1L1
|
factor interacting with PAPOLA and CPSF1
|
1.341
|
|
BTK
|
Bruton agammaglobulinemia tyrosine kinase
|
1.34
|
|
TNFRSF10A
|
tumor necrosis factor receptor superfamily, member 10a
|
1.34
|
|
PPIG
|
peptidylprolyl isomerase G (cyclophilin G)
|
1.335
|
|
IL37
|
interleukin 37
|
1.334
|
|
P2RX7
|
purinergic receptor P2X, ligand gated ion channel, 7
|
1.333
|
|
APOE
|
apolipoprotein E
|
1.331
|
|
CACNA1C
|
calcium channel, voltage-dependent, L type, alpha 1C subunit
|
1.331
|
|
ELN
|
elastin
|
1.33
|
|
LCN2
|
lipocalin 2
|
1.33
|
|
IRF3
|
interferon regulatory factor 3
|
1.328
|
|
MORC3
|
MORC family CW-type zinc finger 3
|
1.327
|
|
PXDN
|
peroxidasin
|
1.326
|
|
MYH6
|
myosin, heavy chain 6, cardiac muscle, alpha
|
1.323
|
|
PXDNL
|
peroxidasin-like
|
1.316
|
|
MMP2
|
matrix metallopeptidase 2
|
1.313
|
|
IL6R
|
interleukin 6 receptor
|
1.311
|
|
ADA2
|
adenosine deaminase 2
|
1.309
|
|
AIM2
|
absent in melanoma 2
|
1.308
|
|
IL15
|
interleukin 15
|
1.308
|
|
PIK3CD
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta
|
1.307
|
|
SAA2-SAA4
|
SAA2-SAA4 readthrough
|
1.306
|
|
SAA2
|
serum amyloid A2
|
1.302
|
|
CST3
|
cystatin C
|
1.301
|
|
IL36RN
|
interleukin 36 receptor antagonist
|
1.297
|
|
PDGFRA
|
platelet-derived growth factor receptor, alpha polypeptide
|
1.293
|
|
NLRP1
|
NLR family, pyrin domain containing 1
|
1.292
|
|
IL33R
|
interleukin 33 receptor
|
1.29
|
|
PSTPIP1
|
proline-serine-threonine phosphatase interacting protein 1
|
1.289
|
|
CXCR3
|
chemokine (C-X-C motif) receptor 3
|
1.287
|
|
CD27
|
CD27 molecule
|
1.285
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
1.284
|
|
MYL3
|
myosin, light chain 3, alkali; ventricular, skeletal, slow
|
1.284
|
|
TNFAIP3
|
tumor necrosis factor, alpha-induced protein 3
|
1.278
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
1.277
|
|
CD5
|
CD5 molecule
|
1.276
|
|
PCSK9
|
proprotein convertase subtilisin/kexin type 9
|
1.268
|
|
SAA4
|
serum amyloid A4, constitutive
|
1.265
|
|
IREB2
|
iron-responsive element binding protein 2
|
1.264
|
|
LAG3
|
lymphocyte-activation gene 3
|
1.262
|
|
PIK3CG
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
|
1.262
|
|
ACR
|
acrosin
|
1.262
|
|
KCNA5
|
potassium channel, voltage gated shaker related subfamily A, member 5
|
1.26
|
|
KRT7
|
keratin 7, type II
|
1.259
|
|
MMP3
|
matrix metallopeptidase 3
|
1.258
|
|
GAPDH
|
glyceraldehyde-3-phosphate dehydrogenase
|
1.255
|
|
PTPN22
|
protein tyrosine phosphatase, non-receptor type 22 (lymphoid)
|
1.251
|
|
CD38
|
CD38 molecule
|
1.248
|
|
SLC29A3
|
solute carrier family 29 (equilibrative nucleoside transporter), member 3
|
1.248
|
|
JUN
|
jun proto-oncogene
|
1.248
|
|
KRT5
|
keratin 5, type II
|
1.246
|
|
SH2D3A
|
SH2 domain containing 3A
|
1.244
|
|
KCND3
|
potassium channel, voltage gated Shal related subfamily D, member 3
|
1.239
|
|
BSG
|
basigin (Ok blood group)
|
1.239
|
|
ADRB1
|
adrenoceptor beta 1
|
1.238
|
|
ICOS
|
inducible T-cell co-stimulator
|
1.235
|
|
TG
|
thyroglobulin
|
1.235
|
|
CBR3
|
carbonyl reductase 3
|
1.233
|
|
TRIM33
|
tripartite motif containing 33
|
1.231
|
|
SST
|
somatostatin
|
1.23
|
|
CD52
|
CD52 molecule
|
1.227
|
|
HLA-B
|
major histocompatibility complex, class I, B
|
1.224
|
|
IL9
|
interleukin 9
|
1.223
|
|
B2M
|
beta-2-microglobulin
|
1.222
|
|
PIK3CB
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta
|
1.222
|
|
TBP
|
TATA box binding protein
|
1.222
|
|
HMGB1
|
high mobility group box 1
|
1.218
|
|
TLR8
|
toll-like receptor 8
|
1.216
|
|
IRAK1
|
interleukin-1 receptor-associated kinase 1
|
1.216
|
|
IL36R
|
interleukin 36 receptor
|
1.215
|
|
TNFRSF25
|
tumor necrosis factor receptor superfamily, member 25
|
1.213
|
|
FASLG
|
Fas ligand (TNF superfamily, member 6)
|
1.212
|
|
CXCL1
|
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha)
|
1.211
|
|
SHOC2
|
soc-2 suppressor of clear homolog (C. elegans)
|
1.211
|
|
ADAM17
|
ADAM metallopeptidase domain 17
|
1.211
|
|
IL1F10
|
interleukin 1 family, member 10 (theta)
|
1.208
|
|
APOB
|
apolipoprotein B
|
1.208
|
|
STAT4
|
signal transducer and activator of transcription 4
|
1.204
|
|
ITGA2B
|
integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41)
|
1.204
|
|
XDH
|
xanthine dehydrogenase
|
1.203
|
|
DSP
|
desmoplakin
|
1.2
|
|
FCGR1A
|
Fc fragment of IgG, high affinity Ia, receptor (CD64)
|
1.198
|
|
CYCS
|
cytochrome c, somatic
|
1.198
|
|
TYK2
|
tyrosine kinase 2
|
1.198
|
|
RHOA
|
ras homolog family member A
|
1.196
|
|
PLA2G7
|
phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma)
|
1.189
|
|
CD44
|
CD44 molecule (Indian blood group)
|
1.188
|
|
C4B
|
complement component 4B (Chido blood group)
|
1.188
|
|
ELANE
|
elastase, neutrophil expressed
|
1.181
|
|
LTF
|
lactotransferrin
|
1.179
|
|
WT1
|
Wilms tumor 1
|
1.178
|
|
TNFRSF8
|
tumor necrosis factor receptor superfamily, member 8
|
1.176
|
|
EDNRA
|
endothelin receptor type A
|
1.176
|
|
TARS3
|
threonyl-tRNA synthetase 3
|
1.174
|
|
BCR
|
breakpoint cluster region
|
1.172
|
|
CCL11
|
chemokine (C-C motif) ligand 11
|
1.168
|
|
PYCARD
|
PYD and CARD domain containing
|
1.163
|
|
CCL7
|
chemokine (C-C motif) ligand 7
|
1.162
|
|
IRF5
|
interferon regulatory factor 5
|
1.161
|
|
LMNA
|
lamin A/C
|
1.158
|
|
ITGAX
|
integrin, alpha X (complement component 3 receptor 4 subunit)
|
1.157
|
|
SCARB1
|
scavenger receptor class B, member 1
|
1.154
|
|
FLT3
|
fms-related tyrosine kinase 3
|
1.152
|
|
F7
|
coagulation factor VII (serum prothrombin conversion accelerator)
|
1.147
|
|
SDC1
|
syndecan 1
|
1.147
|
|
CTSB
|
cathepsin B
|
1.146
|
|
PKP2
|
plakophilin 2
|
1.145
|
|
CTSL
|
cathepsin L
|
1.145
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
1.143
|
|
TIMP1
|
TIMP metallopeptidase inhibitor 1
|
1.141
|
|
EIF2AK2
|
eukaryotic translation initiation factor 2-alpha kinase 2
|
1.141
|
|
HAVCR1
|
hepatitis A virus cellular receptor 1
|
1.139
|
|
NEK7
|
NIMA-related kinase 7
|
1.135
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
1.135
|
|
DMD
|
dystrophin
|
1.135
|
|
CXCL13
|
chemokine (C-X-C motif) ligand 13
|
1.133
|
|
TNFRSF9
|
tumor necrosis factor receptor superfamily, member 9
|
1.133
|
|
NELFCD
|
negative elongation factor complex member C/D
|
1.13
|
|
CTNS
|
cystinosin, lysosomal cystine transporter
|
1.129
|
|
IL2RA
|
interleukin 2 receptor, alpha
|
1.129
|
|
TARS2
|
threonyl-tRNA synthetase 2, mitochondrial (putative)
|
1.123
|
|
CCR2
|
chemokine (C-C motif) receptor 2
|
1.117
|
|
SPP1
|
secreted phosphoprotein 1
|
1.117
|
|
MYL2
|
myosin, light chain 2, regulatory, cardiac, slow
|
1.115
|
|
CD36
|
CD36 molecule (thrombospondin receptor)
|
1.115
|
|
MUC1
|
mucin 1, cell surface associated
|
1.113
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
1.111
|
|
SLC28A3
|
solute carrier family 28 (concentrative nucleoside transporter), member 3
|
1.111
|
|
KCNA3
|
potassium channel, voltage gated shaker related subfamily A, member 3
|
1.11
|
|
CD247
|
CD247 molecule
|
1.108
|
|
ART1
|
ADP-ribosyltransferase 1
|
1.108
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
1.107
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
1.107
|
|
TNFRSF13C
|
tumor necrosis factor receptor superfamily, member 13C
|
1.106
|
|
IL7R
|
interleukin 7 receptor
|
1.106
|
|
LEP
|
leptin
|
1.104
|
|
HAMP
|
hepcidin antimicrobial peptide
|
1.103
|
|
SCARB2
|
scavenger receptor class B, member 2
|
1.101
|
|
MBL2
|
mannose-binding lectin (protein C) 2, soluble
|
1.101
|
|
TNFRSF1B
|
tumor necrosis factor receptor superfamily, member 1B
|
1.101
|
|
UBA1
|
ubiquitin-like modifier activating enzyme 1
|
1.1
|
|
TLR1
|
toll-like receptor 1
|
1.098
|
|
CXADR
|
coxsackie virus and adenovirus receptor
|
1.098
|
|
C1R
|
complement component 1, r subcomponent
|
1.097
|
|
HAVCR2
|
hepatitis A virus cellular receptor 2
|
1.094
|
|
CYP2C9
|
cytochrome P450, family 2, subfamily C, polypeptide 9
|
1.093
|
|
TARS1
|
threonyl-tRNA synthetase 1
|
1.089
|
|
MX1
|
MX dynamin-like GTPase 1
|
1.088
|
|
PSMB8
|
proteasome (prosome, macropain) subunit, beta type, 8
|
1.088
|
|
CCR7
|
chemokine (C-C motif) receptor 7
|
1.087
|
|
DUOX1
|
dual oxidase 1
|
1.086
|
|
CTSS
|
cathepsin S
|
1.086
|
|
TRAF6
|
TNF receptor-associated factor 6, E3 ubiquitin protein ligase
|
1.086
|
|
CCR5
|
chemokine (C-C motif) receptor 5 (gene/pseudogene)
|
1.081
|
|
ACTB
|
actin, beta
|
1.079
|
|
DNASE1L3
|
deoxyribonuclease I-like 3
|
1.079
|
|
FGF7
|
fibroblast growth factor 7
|
1.078
|
|
PDE5A
|
phosphodiesterase 5A, cGMP-specific
|
1.076
|
|
LDLR
|
low density lipoprotein receptor
|
1.076
|
|
IL3
|
interleukin 3
|
1.076
|
|
BBOX1
|
butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1
|
1.075
|
|
HLA-DQA1
|
major histocompatibility complex, class II, DQ alpha 1
|
1.073
|
|
LTA
|
lymphotoxin alpha
|
1.071
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
1.069
|
|
ACTC1
|
actin, alpha, cardiac muscle 1
|
1.068
|
|
NKX2-1
|
NK2 homeobox 1
|
1.067
|
|
MMP1
|
matrix metallopeptidase 1
|
1.066
|
|
IRF7
|
interferon regulatory factor 7
|
1.066
|
|
TRAT1
|
T cell receptor associated transmembrane adaptor 1
|
1.066
|
|
IFI16
|
interferon, gamma-inducible protein 16
|
1.062
|
|
CYP2C19
|
cytochrome P450, family 2, subfamily C, polypeptide 19
|
1.059
|
|
CD69
|
CD69 molecule
|
1.058
|
|
NFKBIA
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha
|
1.055
|
|
GCG
|
glucagon
|
1.053
|
|
CYP2D6
|
cytochrome P450, family 2, subfamily D, polypeptide 6
|
1.051
|
|
ERCC6
|
excision repair cross-complementation group 6
|
1.05
|
|
ESR1
|
estrogen receptor 1
|
1.05
|
|
FGF23
|
fibroblast growth factor 23
|
1.05
|
|
NRG1
|
neuregulin 1
|
1.049
|
|
MAVS
|
mitochondrial antiviral signaling protein
|
1.048
|
|
KCNQ1
|
potassium channel, voltage gated KQT-like subfamily Q, member 1
|
1.048
|
|
SH2D3C
|
SH2 domain containing 3C
|
1.047
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
1.045
|
|
CXCL11
|
chemokine (C-X-C motif) ligand 11
|
1.044
|
|
ADM
|
adrenomedullin
|
1.04
|
|
PTPN11
|
protein tyrosine phosphatase, non-receptor type 11
|
1.038
|
|
HSPB3
|
heat shock 27kDa protein 3
|
1.036
|
|
HARS1
|
histidyl-tRNA synthetase 1
|
1.035
|
|
FGF18
|
fibroblast growth factor 18
|
1.035
|
|
UNC13D
|
unc-13 homolog D (C. elegans)
|
1.033
|
|
KCNN3
|
potassium channel, calcium activated intermediate/small conductance subfamily N alpha, member 3
|
1.032
|
|
FGF2
|
fibroblast growth factor 2 (basic)
|
1.032
|
|
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)
|
1.03
|
|
MAS1L
|
MAS1 proto-oncogene like, G protein-coupled receptor
|
1.029
|
|
FGF17
|
fibroblast growth factor 17
|
1.028
|
|
LPIN2
|
lipin 2
|
1.027
|
|
PYGB
|
phosphorylase, glycogen; brain
|
1.027
|
|
FGF5
|
fibroblast growth factor 5
|
1.025
|
|
FGF22
|
fibroblast growth factor 22
|
1.024
|
|
CGAS
|
cyclic GMP-AMP synthase
|
1.024
|
|
FGF6
|
fibroblast growth factor 6
|
1.022
|
|
FGF16
|
fibroblast growth factor 16
|
1.022
|
|
ENG
|
endoglin
|
1.021
|
|
FGF20
|
fibroblast growth factor 20
|
1.02
|
|
SMAD4
|
SMAD family member 4
|
1.02
|
|
FGF4
|
fibroblast growth factor 4
|
1.02
|
|
RAG1
|
recombination activating gene 1
|
1.019
|
|
SIRT1
|
sirtuin 1
|
1.019
|
|
FGF3
|
fibroblast growth factor 3
|
1.019
|
|
STING1
|
stimulator of interferon response cGAMP interactor 1
|
1.017
|
|
OXCT1
|
3-oxoacid CoA transferase 1
|
1.014
|
|
APOA1
|
apolipoprotein A-I
|
1.014
|
|
PTX3
|
pentraxin 3, long
|
1.012
|
|
HLA-DQB1
|
major histocompatibility complex, class II, DQ beta 1
|
1.012
|
|
CEACAM1
|
carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein)
|
1.011
|
|
CASP8
|
caspase 8, apoptosis-related cysteine peptidase
|
1.01
|
|
FGF8
|
fibroblast growth factor 8 (androgen-induced)
|
1.01
|
|
CMA1
|
chymase 1, mast cell
|
1.01
|
|
CP
|
ceruloplasmin (ferroxidase)
|
1.009
|
|
ANPEP
|
alanyl (membrane) aminopeptidase
|
1.009
|
|
C1S
|
complement component 1, s subcomponent
|
1.009
|
|
PRL
|
prolactin
|
1.006
|
|
MMP8
|
matrix metallopeptidase 8
|
1.005
|
|
FGF9
|
fibroblast growth factor 9
|
1.005
|
|
FGF10
|
fibroblast growth factor 10
|
1.005
|
|
RNASE3
|
ribonuclease, RNase A family, 3
|
1.005
|
|
AGTR2
|
angiotensin II receptor, type 2
|
1.004
|
|
SMAD3
|
SMAD family member 3
|
1.003
|
|
LAX1
|
lymphocyte transmembrane adaptor 1
|
1.003
|
|
EGF
|
epidermal growth factor
|
1.003
|
|
IL12RB1
|
interleukin 12 receptor, beta 1
|
1.002
|
|
TLR5
|
toll-like receptor 5
|
1.001
|
|
OLR1
|
oxidized low density lipoprotein (lectin-like) receptor 1
|
1.0
|
